Experiments performed with DMOG demonstrated that the inhibition of PHDs directly control the expression of Sdc-3, and we confirmed this finding with a HIF-1α deficient tumor cell line, and by the identification of several HREs on the Sdc-3 promoter. Here, SDC3 is linked to neoplasm.